Zobrazeno 1 - 10
of 312
pro vyhledávání: '"immunogenic cell death (ICD)"'
Publikováno v:
Chemistry, Vol 6, Iss 3, Pp 345-360 (2024)
The conjugate of rhein and artesunate have shown promising effects in inducing immunogenic cell death (ICD) and inhibiting tumor growth. Rhein, a natural anthraquinone derivative found in various medicinal plants such as Rheum palmatum, possesses div
Externí odkaz:
https://doaj.org/article/844c7156e285458694777fdeea99abf6
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionThis study leverages bioinformatics and medical big data to integrate datasets from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA), providing a comprehensive overview of immunogenic cell death (ICD)-related gene expr
Externí odkaz:
https://doaj.org/article/a82d375efae249cfba96749e5447b03b
Publikováno v:
Malaria Journal, Vol 23, Iss 1, Pp 1-14 (2024)
Abstract Background Immunogenic cell death (ICD) is a type of regulated cell death that plays a crucial role in activating the immune system in response to various stressors, including cancer cells and pathogens. However, the involvement of ICD in th
Externí odkaz:
https://doaj.org/article/c79f033473c04c84ab5a1b6b7db207fe
Autor:
Baoyuan Zhang, Ning Li, Jiaming Gao, Yuxi Zhao, Jun Jiang, Shuang Xie, Cuiping Zhang, Qingyu Zhang, Leo Liu, Zaiqi Wang, Dongmei Ji, Lingying Wu, Ruibao Ren
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-21 (2024)
Abstract Backgrounds Immune checkpoint blockade (ICB) is widely considered to exert long-term treatment benefits by activating antitumor immunity. However, many cancer patients show poor clinical responses to ICB due in part to the lack of an immunog
Externí odkaz:
https://doaj.org/article/f6130e669747441399b8af4774e9863a
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Cancer immunotherapy, such as immune checkpoint blockade (ICB), has emerged as a groundbreaking approach for effective cancer treatment. Despite its considerable potential, clinical studies have indicated that the current response rate to cancer immu
Externí odkaz:
https://doaj.org/article/6f2442c7539543b095810ad7cc493d3a
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 12 (2024)
Immunotherapy has emerged as a promising cancer treatment option in recent years. In immune “hot” tumors, characterized by abundant immune cell infiltration, immunotherapy can improve patients’ prognosis by activating the function of immune cel
Externí odkaz:
https://doaj.org/article/c862c4979c524054b5b7608026f9b0d7
Autor:
Yang Yang, Yefei Zhu, Kairuo Wang, Yunqiu Miao, Yuanyuan Zhang, Jie Gao, Huanlong Qin, Yang Zhang
Publikováno v:
Bioactive Materials, Vol 29, Iss , Pp 116-131 (2023)
Chemotherapy can induce a robust T cell antitumor immune response by triggering immunogenic cell death (ICD), a process in which tumor cells convert from nonimmunogenic to immunogenic forms. However, the antitumor immune response of ICD remains limit
Externí odkaz:
https://doaj.org/article/3fc7e4c867054577992c5f2b4f65aef5
Autor:
Shushan Zhang, Yongquan Huang, Songying Pi, Hui Chen, Feile Ye, Chaoqun Wu, Liujun Li, Qing Ye, Yuhong Lin, Zhongzhen Su
Publikováno v:
Journal of Nanobiotechnology, Vol 21, Iss 1, Pp 1-22 (2023)
Abstract Incomplete radiofrequency ablation (IRFA) triggers mild protective autophagy in residual tumor cells and results in an immunosuppressive microenvironment. This accelerates the recurrence of residual tumors and causes resistance to anti-PD-1/
Externí odkaz:
https://doaj.org/article/0312779b2dce48388c736eb9cb5d96cd
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
Externí odkaz:
https://doaj.org/article/21a97d5dc6f24283a4a364fd4fcbc0e3
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-19 (2023)
Abstract A growing body of evidence indicates that the anticancer effect of the immune system can be activated by the immunogenic modulation of dying cancer cells. Cancer cell death, as a result of the activation of an immunomodulatory response, is c
Externí odkaz:
https://doaj.org/article/4225a8a483d64b4e9844bcd3856e882b